NCT02551549View on ClinicalTrials.gov

An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Healthy
Interventions
DRUG

CD101 IV

antifungal

DRUG

Placebo

Normal saline

Trial Locations (1)

85283

Celerion Inc, Tempe

Sponsors
All Listed Sponsors
lead

Cidara Therapeutics Inc.

INDUSTRY